triazoles has been researched along with 8-hydroxy-2'-deoxyguanosine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawa, Y; Tayama, S | 1 |
| Furukawa, A; Harada, K; Hiraku, Y; Kawanishi, S; Murata, M; Oikawa, S; Shimada, A; Sugiyama, H | 1 |
| Hayashi, T; Iyama, S; Kaneko, Y; Kato, J; Kawano, Y; Kikuchi, S; Kobune, M; Miyanishi, K; Murase, K; Ono, K; Sato, T; Sato, Y; Takada, K; Takimoto, R | 1 |
| Fujita, H; Hayashi, H; Kikuchi, N; Komatsu, K; Komatsu, T; Murayama, H; Narita, T; Ohshiro, H; Sato, S; Taniai, H; Yamada, Y | 1 |
1 trial(s) available for triazoles and 8-hydroxy-2'-deoxyguanosine
| Article | Year |
|---|---|
DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1α in type 2 diabetic patients with incipient nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Chemokine CXCL12; Cross-Over Studies; Cyclic AMP; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Middle Aged; Piperidines; Pyrazines; Receptor, Angiotensin, Type 1; Sitagliptin Phosphate; Triazoles; Up-Regulation; Uracil | 2014 |
3 other study(ies) available for triazoles and 8-hydroxy-2'-deoxyguanosine
| Article | Year |
|---|---|
Induction of 8-hydroxy-2'-deoxyguanosine in CHO-K1 cells exposed to phenyl-hydroquinone, a metabolite of ortho-phenylphenol.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antidotes; Biphenyl Compounds; Cell Survival; CHO Cells; Cricetinae; Deferoxamine; Deoxyguanosine; DNA Damage; Glutathione; Hydroquinones; Triazoles | 1996 |
Oxidatively generated DNA damage induced by 3-amino-5-mercapto-1,2,4-triazole, a metabolite of carcinogenic amitrole.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Amitrole; Carcinogens; Chelating Agents; Copper; Cyclin-Dependent Kinase Inhibitor p16; Deoxyguanosine; DNA Damage; Humans; Liver Neoplasms; Neoplasm Proteins; Oxygen; Phenanthrolines; ras Proteins; Sodium Azide; Thyroid Neoplasms; Triazoles; Tumor Suppressor Protein p53 | 2010 |
Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Antigens, CD; Benzoates; Case-Control Studies; Deferasirox; Deoxyguanosine; DNA Damage; Erythrocyte Transfusion; Ferritins; Genome, Human; Humans; Iron Chelating Agents; Iron Overload; Leukocytes, Mononuclear; Myelodysplastic Syndromes; Prospective Studies; Reactive Oxygen Species; Statistics, Nonparametric; Triazoles | 2012 |